Description
Title: Immune check point inhibitors’ pulmonary toxicity in the treatment of cancer: a brief review
Abstract: Immune-checkpoint inhibitors (ICIs) have transformed how solid tumors are treated, sometimes producing long-lasting responses. But an uncontrolled immune response may result in minor to major immune-related adverse events (irAEs). Although Immune checkpoint inhibitor-related pneumonitis (ICI-pneumonitis) is a term that is frequently used to refer to pulmonary toxicity, it actually covers a wide range of pulmonary symptoms that can occur in combination or alone in about 10% of patients taking ICI. The actual numbers in real-world populations are high, though, and they will probably rise as more malignancies are included in the therapeutic indications for ICIs. The cornerstone of treatment for ICI-pneumonitis is drug withdrawal. But many patients with higher levels of toxicity might require corticosteroids. Additional immunosuppressive medications are required for patients with refractory disease. We briefly review the incidence, risk factors, mechanisms, clinical and radiologic manifestations, diagnosis, and current management approaches of ICI-pneumonitis in this review.
Keywords: cancer, immune check point inhibitors, immunotherapy, pulmonary toxicity
Paper Quality: SCOPUS / Web of Science Level Research Paper
Subject: Advances in Respiratory Medicine
Writer Experience: 20+ Years
Plagiarism Report: Turnitin Plagiarism Report will be less than 10%
Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.
What will I get after the purchase?
A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.
In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915
Reviews
There are no reviews yet.